Cargando…
Altered increase in STAT1 expression and phosphorylation in severe COVID‐19
The interferon pathway, a key antiviral defense mechanism, is being considered as a therapeutic target in COVID‐19. Both, substitution of interferon and JAK/STAT inhibition to limit cytokine storms have been proposed. However, little is known about possible abnormalities in STAT signaling in immune...
Autores principales: | Rincon‐Arevalo, Hector, Aue, Arman, Ritter, Jacob, Szelinski, Franziska, Khadzhynov, Dmytro, Zickler, Daniel, Stefanski, Luisa, Lino, Andreia C., Körper, Sixten, Eckardt, Kai‐Uwe, Schrezenmeier, Hubert, Dörner, Thomas, Schrezenmeier, Eva V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646801/ https://www.ncbi.nlm.nih.gov/pubmed/34676541 http://dx.doi.org/10.1002/eji.202149575 |
Ejemplares similares
-
B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients
por: Stefanski, Ana-Luisa, et al.
Publicado: (2022) -
Persistent but atypical germinal center reaction among 3(rd) SARS-CoV-2 vaccination after rituximab exposure
por: Stefanski, Ana-Luisa, et al.
Publicado: (2022) -
B Cell Numbers Predict Humoral and Cellular Response Upon SARS–CoV‐2 Vaccination Among Patients Treated With Rituximab
por: Stefanski, Ana‐Luisa, et al.
Publicado: (2022) -
Deep Phenotyping of CD11c(+) B Cells in Systemic Autoimmunity and Controls
por: Rincon-Arevalo, Hector, et al.
Publicado: (2021) -
T-cell STAT3 is required for the maintenance of humoral immunity to LCMV
por: McIlwain, David R, et al.
Publicado: (2015)